ABSTRACT
Buruli ulcer (BU) endemicity is changing in Victoria, Australia. This study describes the emergence of BU cases in urban Geelong and examines timing and proximity of human cases to environmental Mycobacterium ulcerans DNA detection in possum faeces. From 2011-2022, 80 BU cases were reported, with clusters emerging in new endemic areas from 2019 onwards. Temporal analysis revealed cases occurred near M. ulcerans positive possum faeces, that preceded human cases by up to 39 months. Median diagnosis delay in these emerging areas was 7 weeks, longer than in established BU endemic areas. The findings emphasise the geographic and temporal association between BU emergence and possum faecal M. ulcerans presence, suggesting monitoring possum faeces as a viable early warning sign of increased BU risk in such areas. This proactive approach can enable early action to improve clinician and community BU awareness, or development of innovative control strategies, to reduce disease burden.
Article Summary Line Our study describes the timing and pattern of Buruli Ulcer emergence in a non-coastal urban setting in Victoria, Australia, providing evidence that the emergence of clustered, locally acquired human cases was preceded by Mycobacterium ulcerans infection in possums up to three years prior.
Author biography Dr. McNamara is an epidemiologist at the Barwon South West Public Health Unit and honorary senior research fellow at the Centre for Epidemiology and Biostatistics at the University of Melbourne. Her research interests focus on social and health equity and applied epidemiology for disease outbreak management and primary prevention, particularly for Buruli ulcer and COVID-19.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The data collection and analysis of the possum faecal surveys were funded as part of the NHMRC Partnership Project Grant 2018-2020 (GNT1152807).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Barwon Health Human Research Ethics Committee gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos